journal article·2022-12Open access

BSA-assisted synthesis of nanoreactors with dual pH and glutathione responses for ferroptosis and photodynamic synergistic therapy of colorectal cancer

Xiaoyan Liang, Min Mu, Bo Chen, Di Chuan, Na Zhao, Rangrang Fan, Xin Tang, Haifeng Chen, Bo Han, Gang Guo

Abstract

Colorectal cancer (CRC) is the third most common cancer in global incidence and second most common cancer in global mortality rates, accounting for 10% of all cancer cases and 9.4% of all cancer-related deaths. CRC is a heterogeneous disease, mostly comprising sporadic tumors. Approximately 19%–28% of patients have postoperative metastasis. In this study, we report an epigallocatechin gallate (EGCG)-based metal polyphenol network (MPN) with CD44 targeting, glutathione (GSH) sensitivity and pH response for the codelivery of the photosensitizers chlorin e6 (Ce6) and Fe3+. Photodynamic therapy (PDT) has become a potential clinical treatment method because of its noninvasive nature, low toxicity and spatiotemporally controlled treatment capability. Ferroptosis is a nonapoptotic cell death caused by peroxidative modification of phospholipid membranes via iron-dependent mechanisms. We unified ferroptosis and PDT into a nanoreactor (BSA-Ce6@MPN, BCM) to treat CRC. In vitro analysis showed that laser-irradiated BCM increased the cellular reactive oxygen species (ROS) and lipid peroxide (LPO) contents and decreased the expression levels of GSH and glutathione peroxidase 4 (GPX4). BCM-mediated ferroptosis and PDT synergistic therapy were significantly effective in the CT26 tumor-bearing mouse model, demonstrating the efficacy of the combination therapy. These results suggest that the nanoreactor for the synergistic treatment of ferroptosis and PDT holds great promise for clinical translation.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Nanoplatforms for cancer theranostics · Ferroptosis and cancer prognosis · Photodynamic Therapy Research Studies

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (45)

Show source-provided references
1. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
2. Inhibition of autophagy with chloroquine enhanced sinoporphyrin sodium mediated photodynamic therapy-induced apoptosis in human colorectal cancer cells10.7150/ijbs.27156 ↗
3. Tumor-targeted nanoplatform for in situ oxygenation-boosted immunogenic phototherapy of colorectal cancer10.1016/j.actbio.2020.01.012 ↗
4. Whether patients with stage/colorectal cancer benefit from adjuvant chemotherapy: a modeling analysis of literature aggregate data10.3389/fphar.2022.826785 ↗
5. Hypoxia-responsive nanomedicine to overcome tumor microenvironment-mediated resistance to chemo-photodynamic therapy
6. Engineered metal and their complexes for nanomedicine-elicited cancer immunotherapy
7. Manipulating the dynamics of dark excited states in organic materials for phototheranostics10.1021/acs.accounts.0c00688 ↗
8. Achieving efficient NIR-II type-I photosensitizers for photodynamic/photothermal therapy upon regulating chalcogen elements10.1002/adma.202108146 ↗
9. In Vivo-assembled phthalocyanine/albumin supramolecular complexes combined with a hypoxia-activated prodrug for enhanced photodynamic immunotherapy of cancer10.1016/j.biomaterials.2020.120430 ↗
10. Photosensitizer IR700DX-6T- and IR700DX-mbc94-mediated photodynamic therapy markedly elicits anticancer immune responses during treatment of pancreatic cancer10.1016/j.phrs.2021.105811 ↗
11. Transition metal complexes and photodynamic therapy from a tumor-centered approach: challenges, opportunities, and highlights from the development of TLD143310.1021/acs.chemrev.8b00211 ↗
12. An unexpected strategy to alleviate hypoxia limitation of photodynamic therapy by biotinylation of photosensitizers10.1038/s41467-022-29862-9 ↗
13. Porphyrin and nonporphyrin photosensitizers in oncology: preclinical and clinical advances in photodynamic therapy10.1111/j.1751-1097.2009.00585.x ↗
14. Rationally designed ruthenium complexes for 1- and 2-photon photodynamic therapy10.1038/s41467-020-16993-0 ↗
15. Tumor acidity and near-infrared light responsive dual drug delivery polydopamine-based nanoparticles for chemo-photothermal therapy10.1002/adfm.202009733 ↗
16. A Tumor-Specific Ferric-Coordinated Epigallocatechin-3-gallate cascade nanoreactor for glioblastoma therapy10.1016/j.jare.2021.07.010 ↗
17. Folic acid-functionalized tea polyphenol as a tumor-targeting nano-drug delivery system10.1016/j.matdes.2021.109805 ↗
18. Pyrogallol 2-aminoethane: a plant flavonoid-inspired molecule for material-independent surface chemistry10.1002/admi.201400113 ↗
19. Engineering multifunctional capsules through the assembly of metal-phenolic networks10.1002/anie.201311136 ↗
20. One-step assembly of coordination complexes for versatile film and particle engineering10.1126/science.1237265 ↗
21. Promotion of the anticancer activity of curcumin based on a metal-polyphenol networks delivery system10.1016/j.ijpharm.2021.120650 ↗
22. Engineering a pH/glutathione-responsive tea polyphenol nanodevice as an apoptosis/ferroptosis-inducing agent10.1021/acsabm.0c00225 ↗
23. Ferroptosis: a regulated cell death nexus linking metabolism
24. Ferroptosis: an iron-dependent form of nonapoptotic cell death10.1016/j.cell.2012.03.042 ↗
25. SnapShot: ferroptosis10.1016/j.cell.2020.04.039 ↗
26. The role of ferroptosis in ionizing radiation-induced cell death and tumor suppression10.1038/s41422-019-0263-3 ↗
27. Targeting ferroptosis to iron out cancer10.1016/j.ccell.2019.04.002 ↗
28. Ferroptosis: molecular mechanisms and health implications10.1038/s41422-020-00441-1 ↗
29. DHODH-mediated ferroptosis defence is a targetable vulnerability in cancer10.1038/s41586-021-03539-7 ↗
30. Hyaluronic acid-targeted and pH-responsive drug delivery system based on metal-organic frameworks for efficient antitumor therapy10.1016/j.biomaterials.2019.119473 ↗
31. Biodegradable polydopamine and tetrasulfide bond co-doped hollowed mesoporous silica nanospheres as GSH-triggered nanosystem for synergistic chemo-photothermal therapy of breast cancer10.1016/j.matdes.2022.110467 ↗
32. CD44 assists the topical anti-psoriatic efficacy of curcumin-loaded hyaluronan-modified ethosomes: a new strategy for clustering drug in inflammatory skin10.7150/thno.29715 ↗
33. Nanocarrier-based tumor-targeting drug delivery systems for hepatocellular carcinoma treatments: enhanced therapeutic efficacy and reduced
34. MOF x biopolymer: collaborative combination of metal-organic framework and biopolymer for advanced anticancer therapy10.1021/acsami.9b05736 ↗
35. Probing the impact of sulfur/selenium/carbon linkages on prodrug nanoassemblies for cancer therapy10.1038/s41467-019-11193-x ↗
36. A tubular DNA nanodevice as a siRNA/chemo-drug Co-delivery vehicle for combined cancer therapy10.1002/anie.202009842 ↗
37. Chitosan coated pH-responsive metal-polyphenol delivery platform for melanoma chemotherapy10.1016/j.carbpol.2021.118000 ↗
38. Thiol-mediated synthesis of hyaluronic acid-epigallocatechin-3-O-gallate conjugates for the formation of injectable hydrogels with free radical scavenging property and degradation resistance10.1021/acs.biomac.7b00788 ↗
39. Hyaluronic acid-green tea catechin conjugates as a potential therapeutic agent for rheumatoid arthritis10.1039/D1RA01491A ↗
40. Enhanced ferroptosis by oxygen-boosted phototherapy based on a 2-in-1 nanoplatform of ferrous hemoglobin for tumor synergistic therapy10.1021/acsnano.9b09426 ↗
41. Iron-based nanoparticles for MR imaging-guided ferroptosis in combination with photodynamic therapy to enhance cancer treatment10.1039/D0NR08757B ↗
42. Hyaluronic acid binding to TLR4 promotes proliferation and blocks apoptosis in colon cancer10.1158/1535-7163.MCT-18-1225 ↗
43. Circumventing drug resistance pathways with a nanoparticle-based photodynamic method10.1021/acs.nanolett.1c02803 ↗
44. A biodegradable iridium(III) coordination polymer for enhanced two-photon photodynamic therapy using an apoptosis-ferroptosis hybrid pathway
45. Nanoparticle-stabilized oxygen microcapsules prepared by interfacial polymerization for enhanced oxygen delivery10.1002/anie.202100752 ↗